Canarypox virus | |
---|---|
Virus classification | |
(unranked): | Virus |
Realm: | Varidnaviria |
Kingdom: | Bamfordvirae |
Phylum: | Nucleocytoviricota |
Class: | Pokkesviricetes |
Order: | Chitovirales |
Family: | Poxviridae |
Genus: | Avipoxvirus |
Species: | Canarypox virus
|
Canarypox virus (CNPV) is an Avipoxvirus and etiologic agent of canarypox, a disease of wild and captive birds that can cause significant losses. Canarypox can enter human cells, but it cannot survive and multiply in human cells.[1] There is a live viral vaccine available which may have beneficial properties against human cancer when used as a mammalian expression vector.[2] (ATCvet code: QI01KD01 (WHO)). Furthermore, the Poximune C vaccine does offer direct protection against CNPV in susceptible birds.[3]
Generally CNPV is considered a disease of songbirds, such as canaries, magpies and nightingales, and is associated with higher mortality rates when compared to other avian pox viruses.[4] In some instances, mortality approaches 100%.[4] Avian pox viruses also cause significant economic losses in domestic poultry and remain a problem in the conservation of endemic bird species inhabiting islands.[5]
The general symptoms of CNPV are similar to those of other species of avian pox viruses and are characterised by pustules and diphtheria or pneumonia-like symptoms.[1]